Search Results - Sekwon Jang
- Showing 1 - 8 results of 8
-
1
-
2
-
3
-
4
-
5
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms by Charles W. Abbott, Sean M. Boyle, Rachel Marty Pyke, Lee McDaniel, Éric Levy, Fábio C. P. Navarro, Dattatreya Mellacheruvu, Simo V. Zhang, Mengyao Tan, Rose Santiago, Zeid M. Rusan, Pamela Milani, Gábor Bartha, Jason Harris, Rena McClory, M Snyder, Sekwon Jang, Richard Chen
Published 2021Artigo -
6
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma by Adi Diab, Scott S. Tykodi, Gregory A. Daniels, Michele Maio, Brendan D. Curti, Karl D. Lewis, Sekwon Jang, Ewa Kalinka‐Warzocha, Igor Puzanov, Alexander I. Spira, Daniel C. Cho, Shanhong Guan, Erika Puente-Poushnejad, Tuan Nguyen, Ute Hoch, Sue Currie, Wei Lin, Mary Tagliaferri, Jonathan Zalevsky, Mario Sznol, Michael E. Hurwitz
Published 2021Artigo -
7
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204) by Hussein A. Tawbi, Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Thomas, John A. Glaspy, Sekwon Jang, Alain P. Algazi, Nikhil I. Khushalani, Michael A. Postow, Anna C. Pavlick, Marc S. Ernstoff, David A. Reardon, Igor Puzanov, Ragini R. Kudchadkar, Ahmad A. Tarhini, Anne Sumbul, Jasmine I. Rizzo, Kim Margolin
Published 2021Artigo -
8
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre... by Hussein A. Tawbi, Peter Forsyth, F. Stephen Hodi, Alain P. Algazi, Omid Hamid, Christopher D. Lao, Stergios J. Moschos, Michael B. Atkins, Karl D. Lewis, Michael A. Postow, Reena Thomas, John A. Glaspy, Sekwon Jang, Nikhil I. Khushalani, Anna C. Pavlick, Marc S. Ernstoff, David A. Reardon, Ragini R. Kudchadkar, Ahmad A. Tarhini, Caroline Chung, Corey Ritchings, Piyush Durani, Margarita Askelson, Igor Puzanov, Kim Margolin
Published 2021Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Immunotherapy
Oncology
Nivolumab
Cancer research
Ipilimumab
Melanoma
Asymptomatic
Cohort
Immune checkpoint
Immune system
Immunology
Surgery
Antiangiogenic therapy
Arthritis
Biology
Biomarker
Blockade
Clinical endpoint
Clinical trial
Cohort study
Confidence interval
Demography
Dermatology
Disease
Exome
Exome sequencing
First line